BioShares Biotechnology Clinical Trials shows Downside Deviation of 1.86, Risk Adjusted Performance of 0.0863 and Mean Deviation of 1.26. BioShares Biotechnology technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the entity future prices. In plain English you can use this information to find out if the entity will indeed mirror its model of historical prices and volume momentum or the prices will eventually revert. We found nineteen technical drivers for BioShares Biotechnology Clinical Trials which can be compared to its rivals. Please confirm BioShares Biotechnology Maximum Drawdown, Semi Variance and the relationship between Jensen Alpha and Potential Upside to decide if BioShares Biotechnology is priced correctly providing market reflects its regular price of 29.85 per share.
|Time Horizon||30 Days Login to change|
BioShares Biotechnology Technical Analysis
BioShares Biotechnology Trend AnalysisUse this graph to draw trend lines for BioShares Biotechnology Clinical Trials. You can use it to identify possible trend reversals for BioShares Biotechnology as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual BioShares Biotechnology price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.
BioShares Biotechnology Best Fit Change LineThe following chart estimates an ordinary least squares regression model for BioShares Biotechnology Clinical Trials applied against its price change over selected period. The best fit line has a slop of 0.17 % which may imply that BioShares Biotechnology Clinical Trials will maintain its good market sentiment and make money for investors. It has 34 observation points and a regression sum of squares at 23.5, which is the sum of squared deviations for the predicted BioShares Biotechnology price change compared to its average price change.
BioShares Biotechnology Clinical Trials is the top ETF in mean deviation as compared to similar ETFs. It is currently under evaluation in standard deviation as compared to similar ETFs creating about 1.33 of Standard Deviation per Mean Deviation. The ratio of Standard Deviation to Mean Deviation for BioShares Biotechnology Clinical Trials is roughly 1.33